Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

This example shows findings from an assessment of genomic variations in human leukocyte antigens (HLA) with the purpose of determining genotyping of 


Genotyping of the human leucocyte antigen (HLA) is indispensable for transplantation of hematopoietic stem cells or organs [1–3] and for the management of other diseases involving immune reactions [4].




how variations in those genes affect drug absorption, distribution, metabolism, and excretion (ADME).


The method used to summarize nucleotide variation is represented in variable GFANMETH where appropriate. Identifying information for the genomic panel is represented in SPDEVID. Additional information about the genomic panel may be represented in the Medical Device Domains (e.g., DI domain) as needed.





This example shows findings from an assessment of the unique pattern of sequence variation of one to many loci associated



<> with the purpose of determining <>.


An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process.



Human leukocyte antigen (HLA) typing

...

Dataset wrap
Namegf
Rowcaps
Rows 1-6, 9-14:




Date/Time of Reference Time Point
Dataset2
tableidgf
Study IdentifierDomain AbbreviationUnique Subject IdentifierSponsor Device IdentifierNon-Host Organism IdentifierSequence NumberGroup IDReference IDSponsor-Defined IdentifierLink IDLink Group IDShort Name of Genomic MeasurementName of Genomic MeasurementMeasurement, Test, or Examination DetailResult or Finding in Original UnitsGenomic SymbolGenomic Symbol TypeCopy IdentifierCompletion StatusReason Test Not DoneExternal File PathLaboratory/Vendor NameSpecimen Material TypeMethod of Test or ExaminationRun IDAnalysis MethodBaseline FlagDerived FlagLower Limit of QuantitationRepetition NumberVisit NumberVisit NamePlanned Study Day of VisitDate/Time of Specimen CollectionStudy Day of Specimen CollectionPlanned Time Point NamePlanned Time Point NumberPlanned Elapsed Time from Time Point RefTime Point Reference
STUDYIDDOMAINUSUBJIDSPDEVIDNHOIDGFSEQGFGRPIDGFREFIDGFSPIDGFLNKIDGFLNKGRPGFTESTCDGFTESTGFTSTDTLGFORRESGFSYMGFSYMTYPGFCOPYIDGFSTATGFREASNDGFXFNGFNAMGFSPECGFMETHODGFRUNIDGFANMETHGFBLFLGFDRVFLGFLLOQGFREPNUMVISITNUMVISITVISITDYGFDTCGFDYGFTPTGFTPTNUMGFELTMGFTPTREFGFRFTDTC
Study-123GFS123-001

1
HGA4567An assessment of the unique pattern of sequence variation of one to many loci associated with a normal or abnormal biological process.


VARPROFVariant ProfileALLELE TYPEA*02:TSXZHLA-AGENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING





-1SCREENING-19/16/2023-2




Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEA*03:ABSAXHLA-AGENE WITH PROTEIN PRODUCT2


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEB*18:TXYFHLA-BGENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEB*38:01HLA-BGENE WITH PROTEIN PRODUCT2


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEC*07:AAEPNHLA-CGENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEC*12:AAGWEHLA-CGENE WITH PROTEIN PRODUCT2


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDRB1*07:ACEUAHLA-DRB1GENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDRB1*14:ABZZVHLA-DRB1GENE WITH PROTEIN PRODUCT2


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDRB3*01:XXHLA-DRB3GENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDRB3*HLA-DRB3GENE WITH PROTEIN PRODUCT2NOT DONEDRB3*
ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDRB4*01:FVUUHLA-DRB4GENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPE
HLA-DRB4GENE WITH PROTEIN PRODUCT2NOT DONEDRB4*
ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPE
HLA-DRB5GENE WITH PROTEIN PRODUCT1NOT DONEDRB5*
ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPE
HLA-DRB5GENE WITH PROTEIN PRODUCT2NOT DONEDRB5*
ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDQB1*02:ACBXNHLA-DQB1GENE WITH PROTEIN PRODUCT1


ACME GenomicsDNASANGER SEQUENCING















Study-123GFS123-001

1
HGA4567


VARPROFVariant ProfileALLELE TYPEDQB1*05:ACEDBHLA-DQB1GENE WITH PROTEIN PRODUCT2


ACME GenomicsDNASANGER SEQUENCING















...